The triglyceride paradox in the mortality of coronary artery disease

Tian-Li Xia1, Yi-Ming Li2, Fang-Yang Huang1

  • 1Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu, 610041, People's Republic of China.

Insights

Higher triglyceride (TG) levels in coronary artery disease (CAD) patients were associated with a lower risk of long-term mortality. This study suggests a "TG paradox" may be present in CAD secondary prevention.

Area of Science:

  • Cardiology
  • Clinical Research
  • Public Health

Background:

  • The role of triglyceride (TG) in secondary prevention for coronary artery disease (CAD) patients remains debated.
  • This study investigated the association between admission TG levels and long-term mortality risk in CAD patients.

Purpose of the Study:

  • To assess the relationship between admission triglyceride levels and mortality in patients with coronary artery disease.
  • To determine if higher TG levels are associated with increased or decreased long-term mortality in CAD patients.

Main Methods:

  • Retrospective analysis of 3061 CAD patients confirmed by coronary angiography.
  • Patients were categorized into three groups based on admission serum TG tertiles.
  • Primary endpoint: all-cause mortality; Secondary endpoint: cardiovascular mortality.

Main Results:

  • A mean follow-up of 26.9 months revealed 258 deaths and 146 cardiovascular deaths.
  • Cumulative survival analysis showed a decreased risk of all-cause death with increasing TG levels (p=0.001).
  • Cox regression confirmed an independent inverse correlation between TG levels and both all-cause (HR 0.71) and cardiovascular mortality (HR 0.67).

Conclusions:

  • An inverse association exists between triglyceride levels and mortality risk in CAD patients.
  • The findings suggest a potential "TG paradox" in the context of secondary prevention for CAD.
  • This challenges traditional views on TG as solely a risk factor in CAD.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
428
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
369
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
686
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
378